Published in Arzneimittelforschung on June 01, 1967
Retinal sparing by selective retinal pigment epithelial photocoagulation. Arch Ophthalmol (1999) 1.80
Thermal and biomechanical parameters of porcine cornea. Cornea (2000) 1.34
Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a pilot study. Br J Ophthalmol (2000) 1.29
Computerized determination of growth kinetic curves and doubling times from cells in microculture. Anal Biochem (1990) 1.13
Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity. J Cancer Res Clin Oncol (1992) 1.11
Autofluorescence imaging after selective RPE laser treatment in macular diseases and clinical outcome: a pilot study. Br J Ophthalmol (2002) 0.99
The effect of simian immunodeficiency virus infection in vitro and in vivo on the cytokine production of isolated microglia and peripheral macrophages from rhesus monkey. Virology (1996) 0.97
Analysis of lead in soils adjacent to an interstate highway in Tampa, Florida. Environ Geochem Health (1996) 0.96
Selective retina therapy in patients with central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol (2006) 0.95
Inducibility of Ia antigen on astrocytes by murine coronavirus JHM is rat strain dependent. J Exp Med (1987) 0.94
Selective retina therapy for acute central serous chorioretinopathy. Br J Ophthalmol (2010) 0.92
Histologic analysis of thermal effects of laser thermokeratoplasty and corneal ablation using Sirius-red polarization microscopy. J Cataract Refract Surg (1997) 0.91
[Selective retina therapy in central serous chorioretinopathy with detachment of the pigmentary epithelium]. Ophthalmologe (2006) 0.90
HIV-1 gp120 receptor on CD4-negative brain cells activates a tyrosine kinase. Virology (1992) 0.90
Antiestrogens. Synthesis and evaluation of mammary tumor inhibiting activity of 1,1,2,2-tetraalkyl-1,2 -diphenylethanes. J Med Chem (1980) 0.86
Ring-substituted [1,2-bis(4-hydroxyphenyl)ethylenediamine]dichloroplatinum (II) complexes: compounds with a selective effect on the hormone-dependent mammary carcinoma. J Med Chem (1988) 0.85
[Antimicrobial and tumor-inhibiting properties of dithiourethane and studies on the mechanism of action. 16. Cytostatica]. Pharmazie (1972) 0.85
Association and dissociation of visual functions in a case of bilateral occipital lobe infarction. Arch Psychiatr Nervenkr (1970) (1978) 0.84
Hyaluronidase significantly enhances the efficacy of regional vinblastine chemotherapy of malignant melanoma. J Cancer Res Clin Oncol (1995) 0.84
[Optical coherence tomography of the cornea and the anterior eye segment]. Ophthalmologe (1997) 0.82
Vectorial release of matrix metalloproteinases (MMPs) from porcine RPE-choroid explants following selective retina therapy (SRT): towards slowing the macular ageing process. Exp Eye Res (2012) 0.82
[Development of an apparatus for measuring attention in patients with cerebral damage and functional disorders]. J Neurol (1975) 0.82
[Measurement of attention deficit in the course of intoxications (author's transl)]. J Neurol (1975) 0.82
Generation of GW radiation pulses from a VUV free-electron laser operating in the femtosecond regime. Phys Rev Lett (2002) 0.82
Platinum compounds with estrogen receptor affinity. Cancer Treat Rev (1990) 0.81
Variability of RPE reaction in two cases after selective RPE laser effects in prophylactic treatment of drusen. Graefes Arch Clin Exp Ophthalmol (1999) 0.80
1,1,2-triphenylbut-1-enes: relationship between structure, estradiol receptor affinity, and mammary tumor inhibiting properties. J Med Chem (1982) 0.80
The Munich Coma Scle (MCS). J Neurol Neurosurg Psychiatry (1976) 0.80
Continuous-wave diode laser thermokeratoplasty: first clinical experience in blind human eyes. J Cataract Refract Surg (1999) 0.79
Investigations on the antiproliferative effects of amino acid antagonists targeting for aminoacyl-tRNA synthetases. Part II--The antileukemic effect. Arch Pharm (Weinheim) (1989) 0.79
[The course and prognosis of scotomas in patients with cerebrovascular disorders (author's transl)]. Nervenarzt (1977) 0.79
Different response of murine and human mammary tumour models to a series of diastereoisomeric [1,2-bis(difluorophenyl) ethylenediamine]dichloroplatinum(II) complexes. J Cancer Res Clin Oncol (1991) 0.78
[Diode laser thermokeratoplasty. Initial clinical experiences]. Ophthalmologe (1999) 0.78
[Synthesis of 14C-anpirtoline]. Arch Pharm (Weinheim) (1988) 0.78
Interspersion of fragmented fiber's splinters into tissue during pulsed alexandrite laser lithotripsy. Lasers Surg Med (1991) 0.78
[The mode of local anesthetic action of cinchocaine homologues]. Arzneimittelforschung (1970) 0.78
Numerical modelling of conductive and convective heat transfers in retinal laser applications. J Biophotonics (2008) 0.78
A rapid luciferase transfection assay for transcription activation effects and stability control of estrogenic drugs in cell cultures. J Cancer Res Clin Oncol (1994) 0.78
Detection of SIV in rhesus monkey thymus stroma cell cultures. Res Virol (1995) 0.78
Dichloro-[1-(hydroxyphenyl)-2-phenylethylenediamine]platinum(II) complexes: testing on the human ovarian cancer cell lines NIH: OVCAR3 and SK OV 3. Arch Pharm (Weinheim) (1992) 0.78
Laser sclerostomy ab externo using the erbium: YAG laser. First results of a clinical study. Ger J Ophthalmol (1994) 0.77
Benign prostatic hyperplasia. Endocrinol Metab Clin North Am (1994) 0.77
[Shortening diclofenac therapy by B vitamins. Results of a randomized double-blind study, diclofenac 50 mg versus diclofenac 50 mg plus B vitamins, in painful spinal diseases with degenerative changes]. Z Rheumatol (1989) 0.77
Investigations on the antiproliferative effects of amino acid antagonists targeting for aminoacyl-tRNA synthetases. Part I--The antibacterial effect. Arch Pharm (Weinheim) (1989) 0.77
Benzylamines: synthesis and evaluation of antimycobacterial properties. J Med Chem (1984) 0.77
Dissociation of estrogenic and cytotoxic properties of an estrogen receptor-binding platinum complex in human breast cancer cell lines. Cancer Res (1991) 0.77
[Selective retina therapy in patients with diabetic maculopathy]. Ophthalmologe (2006) 0.77
[meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II), a new drug not only parenterally but also orally active in the therapy of breast and prostate cancer. J Cancer Res Clin Oncol (1993) 0.77
Mammary tumor inhibiting [1,2-bis(2,6-dihalo-3-hydroxyphenyl)ethylenediamine]platinum(II) complexes, III: Relationship between structure and estrogenic activity of the diamine ligands, their sulfatoplatinum(II) and diiodoplatinum(II) complexes. Arch Pharm (Weinheim) (1993) 0.76
[1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloro-platinum(II): an endocrine-active platinum complex with a specific prostatic tumor-inhibiting activity. Prostate (1989) 0.76
Stability and cellular studies of [rac-1,2-bis(4-fluorophenyl)-ethylenediamine][cyclobutane-1,1- dicarboxylato]platinum(II), a novel, highly active carboplatin derivative. J Cancer Res Clin Oncol (1998) 0.76
Corneal endothelial cell damage after experimental diode laser thermal keratoplasty. J Refract Surg (2000) 0.76
Chemosensitivity of human MCF-7 breast cancer cells to diastereoisomeric diaqua(1,2-diphenylethylenediamine) platinum(II) sulfates and specific platinum accumulation. Cancer Chemother Pharmacol (1992) 0.76
Computer modelling of estrogenic transcriptional activation can account for different types of dose-response curves of estrogens. J Steroid Biochem Mol Biol (1993) 0.76
N,N'-Dialkyl-1,2-bis(hydroxyphenyl)ethylenediamines and N,N-dialkyl-4,5-bis(4-hydroxyphenyl)imidazolidines: syntheses and evaluation of their mammary tumor inhibiting activity. J Med Chem (1982) 0.76
[Basic principles and clinical application of retinal laser therapy]. Klin Monbl Augenheilkd (2008) 0.76
[Development of new antiestrogens of the 3,3'-dihydroxy-alpha, beta-diethylstilbene-type and their evaluation on the DMBA-induced hormone dependent mammary carcinoma of the SD-rat (author's transl)]. J Cancer Res Clin Oncol (1980) 0.76
Development of a parenterally administrable hydrosol preparation of the "third generation platinum complex" [(+/-)-1,2-bis(4-fluorophenyl)ethylenediamine]dichloroplatinum(II). Part 1. Preparation and studies on the stability and antitumor activity. Arch Pharm (Weinheim) (1995) 0.75
Dichloro[1,2-bis(4-hydroxyphenyl)ethylenediamine]platinum(II) complexes: an approach to develop compounds with a specific effect on the hormone-dependent mammary carcinoma. J Med Chem (1984) 0.75
[Studies on the mechanism of action of local anesthetics. 6. Binding of local anesthetics of complementary membranes structures]. Pharmazie (1972) 0.75
[Studies on the mechanism of the reduction of Schiff bases with activated aluminum in ethyl alcohol. 6. On cytostatic agents]. Arch Pharm Ber Dtsch Pharm Ges (1967) 0.75
[Synthesis of spasmolytic N-diphenylacetamidomethyl-dimethylalkyl-ammonium iodides]. Arch Pharm (Weinheim) (1972) 0.75
Effect of estrophilic platinum complex on the mouse uterus. Virchows Arch B Cell Pathol Incl Mol Pathol (1987) 0.75
[Antineoplastic effect of N,N',N''-trihydroxymethylmelamine and analogous compounds. 23. Cytostatic agents]. Arch Pharm (Weinheim) (1973) 0.75
[Studies of mechanism of action on antimicrobically effective beta-aminoketones]. Pharm Acta Helv (1969) 0.75
Anticancer drugs: estrophilic cisplatin derivatives. Cancer Treat Rev (1987) 0.75
Design of metallocenic drugs. IARC Sci Publ (1986) 0.75
[14C-labeling of D 16,427, a new positive inotropic agent]. Arch Pharm (Weinheim) (1986) 0.75
[Synthesis of hexestrol-isostereo meso-N,N'-dimethyl-alfa,alfa'-di(4-hydroxyphenyl)-ethylenediamine]. Arch Pharm Ber Dtsch Pharm Ges (1970) 0.75
Acetoxy-substituted 1,1,2-triphenylbut-1-enes with antiestrogenic and mammary tumor inhibiting properties. J Med Chem (1985) 0.75
[Synthesis of local anesthetically active alkoxybenhydrylalkylamine from Schiff's bases and phenyllithium]. Arch Pharm Ber Dtsch Pharm Ges (1966) 0.75
[Effect of aminomethylating carcinostatics on experimental animal tumors. IV. On cytostatics]. Arzneimittelforschung (1966) 0.75
Influence of alkyl-chain fluorination on the action of mammary tumor inhibiting 2,3-bis(hydroxyphenyl)butanes and 2,3-bis(hydroxyphenyl)but-2-enes. J Med Chem (1986) 0.75
[Dimer exchange products of aromatic substituted alpha-aminonitriles. VII. Conversion of alpha-aminonitriles]. Arch Pharm Ber Dtsch Pharm Ges (1969) 0.75
[The mode of action of local anesthetics. 7. Synthesis of enantiomeric N-aminoacyl-2.6.-dimethylaniline, -benzylamine and-2-phenylethylamine]. Pharmazie (1976) 0.75
[Dimerization of alpha-piperidinoacetonitrile with t-butylmagnesium chloride. IV. Conversion of alpha-aminonitriles]. Arch Pharm Ber Dtsch Pharm Ges (1969) 0.75
N,N'-Dialkylbis(dichlorophenyl)ethylenediamines and -imidazolidines: relationship between structure and estradiol receptor affinity. J Med Chem (1980) 0.75
A simple method of delayed processing of tumor tissue in a soft agar clonogenic assay. J Cancer Res Clin Oncol (1988) 0.75
[Synthesis and tumor inhibiting effect of N-(bis(2-chlorethyl)-aminomethyl)-amides. 21. Cytostatic agents]. Arch Pharm (Weinheim) (1973) 0.75
[The action mechanisms of local anesthetics. 9. N-aminoacyl-beta-phenylalkylamine tested for development of antidepressive agents from psychotonics]. Pharmazie (1976) 0.75
[Conversions of aliphatic substituted alpha-aminonitriles with metallic sodium in toluol. VI. Conversion of alpha-aminonitriles]. Arch Pharm Ber Dtsch Pharm Ges (1969) 0.75
[Intraocular lenses - aphorisms of an operating practitioner (author's transl)]. Klin Monbl Augenheilkd (1979) 0.75
[Synthesis and local anesthetic effect of N-piperidino-methyl-4-alkoxybenzamides]. Arch Pharm Ber Dtsch Pharm Ges (1970) 0.75
[On the acyl migration of stereoisomers of N-(N-dimethyl-phenylalanyl)-ephedrine. 7. To the separation of organic bases by Craig-distribution]. Arch Pharm Ber Dtsch Pharm Ges (1967) 0.75
[Experimental chemotherapy of mammary neoplasms. A review]. Pharmazie (1976) 0.75
[Influence of solvents on the course of the reduction of Schiff bases with activated aluminum]. Arch Pharm Ber Dtsch Pharm Ges (1965) 0.75
[Configurative assignment of the diastereomer N,N'-dialkyl- , '-diphenylethylenediamines by nucleic resonance spectroscopy. 19. Cytostatics]. Arzneimittelforschung (1972) 0.75
[The relationship between structure and tuberculostatic effect in the benzylamine group]. Pharmazie (1976) 0.75
[The working mechanism of local anesthetics. 8. Preparation of enantiomer N-phthalylamino carbonic acids]. Pharmazie (1976) 0.75
[Mammary-tumor-inhibiting antiestrogens of the 3,3'-dihydroxy-alpha, beta-dialkylstilbene type (author's transl)]. Arch Pharm (Weinheim) (1980) 0.75
[Azomethines and oxazolidines from norfenefrine. Development of compounds with prolonged action and blood pressure increasing effect]. Arch Pharm (Weinheim) (1975) 0.75
[Antimycobacterial effect of N-alkylbenzylamines]. Pharmazie (1977) 0.75
[Chemistry and local anesthetic effect of stereoisomeric N-aminoacylephodrines]. Pharm Acta Helv (1969) 0.75
[Reaction method of alpha-aminoacetonitrile with metallic sodium in liquid ammonia. 8. Conversion of alpha-aminonitriles]. Arch Pharm Ber Dtsch Pharm Ges (1969) 0.75
[Relations between physical-chemical properties and antimicrobial effect of beta-amino-ketones. 9. Cytostatics]. Arzneimittelforschung (1970) 0.75
[Mechanistic studies on the formation of diphenylethylene-diamines from benzylidenealkylamines and activated aluminum. 5. On cytostatic agents]. Arch Pharm Ber Dtsch Pharm Ges (1967) 0.75
[Synthesis and pharmacological test of N-(3'-methoxy-benzamidomethyl)-D-norephedrine and Analogous Compounds (author's transl)]. Arch Pharm (Weinheim) (1976) 0.75
Influence of ring substituents on the antitumor effect of dichloro(1,2-diphenylethylenediamine)platinum(II) complexes. J Cancer Res Clin Oncol (1988) 0.75